Franklin Resources’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.7M Buy
476,004
+2,641
+0.6% +$143K 0.01% 899
2026
Q1
$27.5M Buy
473,363
+137,220
+41% +$7.45M 0.01% 860
2025
Q4
$15.5M Buy
336,143
+37
+0% +$1.66K ﹤0.01% 1032
2025
Q3
$12.1M Sell
336,106
-603,169
-64% -$20M ﹤0.01% 1109
2025
Q2
$30.5M Sell
939,275
-2,149,757
-70% -$70.5M 0.01% 793
2025
Q1
$117M Buy
3,089,032
+219,700
+8% +$17.6M 0.03% 405
2024
Q4
$235M Buy
2,869,332
+82,997
+3% +$8.24M 0.07% 265
2024
Q3
$315M Buy
2,786,335
+324,560
+13% +$29.3M 0.09% 222
2024
Q2
$186M Buy
2,461,775
+314,119
+15% +$21.4M 0.06% 292
2024
Q1
$147M Buy
2,147,656
+1,070,736
+99% +$74.1M 0.05% 333
2023
Q4
$67.6M Buy
1,076,920
+120,985
+13% +$6.28M 0.03% 418
2023
Q3
$48.7M Buy
955,935
+203,536
+27% +$10M 0.02% 504
2023
Q2
$37.6M Buy
752,399
+36,160
+5% +$1.71M 0.02% 603
2023
Q1
$26.8M Buy
716,239
+711,039
+13,674% +$30.2M 0.01% 696
2022
Q4
$249K Buy
+5,200
New +$204K ﹤0.01% 1926
2021
Q1
Sell
-400,076
Closed -$10.6M 2018
2020
Q4
$10.6M Buy
400,076
+6
+0% +$223 ﹤0.01% 952
2020
Q3
$19.8M Hold
400,070
0.01% 772
2020
Q2
$12.7M Buy
+400,070
New +$12.9M 0.01% 826

Other funds holding PCVX

Franklin Resources's PCVX Position: Q2 2026 in Review

Franklin Resources increased its Vaxcyte (PCVX) stake by 0.56% in Q2 2026, buying an estimated $143K and bringing the position to 476,004 shares worth $27.7M. The position accounts for 0.01% of the portfolio, ranked #899.

Franklin Resources first reported a position in PCVX in Q2 2020 and has held it in 18 quarters since. The position peaked at $315M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Franklin Resources held 476,004 shares of Vaxcyte worth $27.7M as of Q2 2026.
  • Franklin Resources bought 2,641 Vaxcyte shares in Q2 2026, an estimated $143K.
  • Vaxcyte made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #899 holding.
  • Franklin Resources first reported a position in Vaxcyte in Q2 2020 and has held it in 18 quarters since.
  • Franklin Resources's Vaxcyte position peaked at $315M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.